Ezra, the health-tech pioneer that has transformed early cancer detection in the US, has launched its AI-powered full-body MRI screening service in the UK – marking a major expansion beyond the US. The next-generation AI-powered screening solution is now available in London, with plans for a nationwide roll out throughout 2025.
As part of the UK launch, Ezra has partnered with Alliance Medical, one of Europe’s leading independent providers of diagnostic imaging services. Alliance Medical will offer Ezra’s full-body MRI scans at its Marylebone clinic, with additional locations to follow. The partnership ensures that Ezra’s AI-driven cancer screening benefits from established clinical expertise and a trusted diagnostic network, making advanced early detection more widely accessible.
Ezra’s AI-powered platform enhances MRI-based cancer screening by significantly reducing scan times, improving clinical workflow efficiencies, and providing an innovative E-SCORE system to help prioritise findings. The service is designed to detect cancer and other serious health conditions early, scanning 13 organs using non-contrast MRI technology, including the brain, liver, kidneys, prostate, uterus, and spine, all in a single 60-minute session.
Cancer Research UK reports a 24% increase in cancer diagnoses among people in their 40s and 50s since 1995. Despite advances in treatment, nearly half of all cancer cases in the UK are still diagnosed at late stages, limiting treatment options and outcomes. Ezra’s mission is to shift this dynamic by making AI-powered early screening more accessible to individuals who may benefit from proactive monitoring, including those with a family history of cancer or other risk factors.
“Having witnessed the impact of late-stage cancer diagnosis in my own family, I understand the critical importance of early detection,” says Emi Gal, CEO and founder of Ezra. “Our mission is to make comprehensive cancer screening fast, accurate and affordable.”
Ezra has already facilitated tens of thousands of scans across 25 US cities, with its AI-powered system enhancing radiology workflows and improving scan interpretation. Each scan is reviewed by specialist radiologists, and findings are categorised with Ezra’s proprietary E-SCORE, allowing clinicians to prioritise results that require urgent follow-up. The company’s technology ensures that full-body MRI remains a non-invasive, radiation-free, and safe alternative for regular screening.
The integration of AI into cancer diagnostics has the potential to optimise radiology workflows, support clinical decision-making, and expand screening capabilities beyond traditional hospital settings. Ezra’s AI technology reduces scan times while maintaining diagnostic accuracy, providing an efficient solution to the growing demand for preventative healthcare services.
“We are delighted to introduce full-body MRI screening in partnership with Ezra. Its AI-driven approach represents the future of early cancer detection, and we are excited to integrate this technology into our imaging services to enhance diagnostic precision and accessibility,” says Peter Winchester, Managing Director of Alliance Medical UK.
“Early detection can dramatically improve cancer survival rates, yet 50% of cancers in the UK are diagnosed at late stages,” says Dr Dan Brook, Ezra’s UK Medical Director. “Our technology provides a powerful new tool for early detection, particularly for individuals with family history or elevated risk factors.”
Scans at the Ezra partner clinic in Marylebone can be booked via the Ezra website (www.ezra.com) from Monday, 24th February 2025, with the company planning to introduce a faster 30-minute MRI scan later this year and expand nationwide in 2025.
Services and pricing:
- Ezra Full Body: £2,395 (13-organ MRI scan)
- Ezra Full Body Plus: £2,695 (includes low-dose chest CT for lung cancer and heart disease screening
Clinicians and healthcare providers can refer patients or book scans directly at www.ezra.com, with results accessible via the secure MyEzra portal. The partnership with Alliance Medical ensures patients benefit from established clinical expertise and cutting-edge AI technology, driving forward a new standard in cancer screening.
